Vitalhub Corp. (TSE:VHI – Get Free Report) has been given an average rating of “Buy” by the seven research firms that are presently covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is C$13.14.
A number of research firms have recently issued reports on VHI. ATB Cormark Capital Markets dropped their price objective on shares of Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 10th. National Bank Financial dropped their price objective on shares of Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Wednesday. Scotiabank dropped their price objective on shares of Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. Finally, Raymond James Financial decreased their price target on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating for the company in a research report on Tuesday, March 24th.
Read Our Latest Stock Analysis on VHI
Vitalhub Stock Up 2.6%
Vitalhub (TSE:VHI – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported C$0.04 earnings per share (EPS) for the quarter. The company had revenue of C$31.91 million for the quarter. Vitalhub had a net margin of 6.13% and a return on equity of 2.98%. Equities analysts expect that Vitalhub will post 0.2296467 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, Director Francis Nelson Shen purchased 50,000 shares of the firm’s stock in a transaction dated Thursday, March 26th. The stock was acquired at an average price of C$6.99 per share, with a total value of C$349,500.00. Following the completion of the transaction, the director owned 50,000 shares of the company’s stock, valued at C$349,500. This represents a ? increase in their ownership of the stock. Also, Director Anthony Pius Shen purchased 7,000 shares of the firm’s stock in a transaction dated Monday, March 30th. The shares were bought at an average cost of C$7.11 per share, with a total value of C$49,770.00. Following the transaction, the director directly owned 12,470 shares of the company’s stock, valued at approximately C$88,661.70. This represents a 127.97% increase in their position. Insiders have bought 496,600 shares of company stock valued at $3,476,470 in the last three months. Corporate insiders own 18.57% of the company’s stock.
Vitalhub Company Profile
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Featured Stories
- Five stocks we like better than Vitalhub
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
